Barely Significant
← all excerpts

Integrative bioinformatics analysis identifies METTL1 as a regulator of immune infiltration and prognosis in breast cancer.

Sci Rep · 2025 · PMC12276251 · PMID 40683927

Europe PMCDOI
1
hedged sentence
0.0470
closest p · 0.9× alpha
0.0470
boldest claim

The sentences

marginally significantp = 0.047actually significant
Additionally, patients with stage III-IV showed slightly higher METTL1 expression than those with stage I-II, with the difference being marginally significant ( p = 0.047) (Fig. 2 D).

also in 26,082 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.